- Home
- / iBio
iBio
Stock Price
$2.8
2024-10-29
Market Capitalization
$26.2 M
2024-10-29
Revenue
$400 K
FY, 2025
iBio Summary
Company Summary
- Overview
- iBio is a biotechnology research company. It develops a discovery platform that offers epitope-steered antibody discovery for precision therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 2008
- HQ
- San Diego, CA, US | view all locations
- Website
- http://ibioinc.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Gary Sender, Director
James T. Hill, Director
Alexandra Kropotova, Director
Operating MetricsView all
Patents Issued
67
FY, 2016
Patents Pending
19
FY, 2016
LocationsView all
2 locations detected
San Diego, CA HQ
United States
11750 Sorrento Valley Road, Suite 200
Bryan, TX
United States
8800 HSC Pkwy
iBio Financials
Summary Financials
- Net income (Q2, 2026)
- ($9.0M)
- Cash (Q2, 2026)
- $28.7M
- EBIT (Q2, 2026)
- ($9.4M)
- Enterprise value
- ($24.2K)